Labiana Health SA

XMAD:LAB (Spain)  
€ 2.48 (0%) Oct 15
At Loss
P/B:
5.00
Market Cap:
€ 17.91M ($ 19.45M)
Enterprise V:
€ 56.66M ($ 61.52M)
Volume:
350.00
Avg Vol (2M):
1.07K
Trade In:
Volume:
350.00
At Loss

Business Description

Description
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.
Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset 0.06
Debt-to-Equity 11.65
Debt-to-EBITDA 13.42
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.06
Distress
Grey
Safe
Beneish M-Score -2.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.99
9-Day RSI 40.92
14-Day RSI 37
6-1 Month Momentum % 93.55
12-1 Month Momentum % 160.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.17
Quick Ratio 0.72
Cash Ratio 0.12
Days Inventory 185.87
Days Sales Outstanding 61.36
Days Payable 157.45

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 11.66